KYNTRA BIO, INC. (KYNB) Operating income 2016–2025
KYNTRA BIO, INC. (KYNB) annual operating income history from SEC filings — each fiscal year as reported.
-$45.9MFY2025 · since FY2016: -$50.0M → -$45.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$45.9M | +69.5% |
| FY2024 | -$150.4M | +53.4% |
| FY2023 | -$322.7M | -7.2% |
| FY2022 | -$301.0M | -4.3% |
| FY2021 | -$288.5M | -50.4% |
| FY2020 | -$191.9M | -114.8% |
| FY2019 | -$89.3M | -3.0% |
| FY2018 | -$86.7M | +26.1% |
| FY2017 | -$117.3M | -134.4% |
| FY2016 | -$50.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice